• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸腔积液具有促进生长的生物学特性,可使癌细胞增殖。

Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation.

作者信息

Asciak Rachelle, Kanellakis Nikolaos I, Yao Xuan, Abd Hamid Megat, Mercer Rachel M, Hassan Maged, Bedawi Eihab O, Dobson Melissa, Fsadni Peter, Montefort Stephen, Dong Tao, Rahman Najib M, Psallidas Ioannis

机构信息

Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.

Laboratory of Pleural and Lung Cancer Translational Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.

出版信息

Front Oncol. 2021 Apr 28;11:658395. doi: 10.3389/fonc.2021.658395. eCollection 2021.

DOI:10.3389/fonc.2021.658395
PMID:33996582
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8115017/
Abstract

OBJECTIVES

Patients with malignant pleural mesothelioma (MPM) or pleural metastases often present with malignant pleural effusion (MPE). This study aimed to analyze the effect of pleural fluid on cancer cells.

MATERIALS AND METHODS

Established patient-derived cancer cell cultures derived from MPE (MPM, breast carcinoma, lung adenocarcinoma) were seeded in 100% pleural fluid (exudate MPM MPE, transudate MPE, non-MPE transudate fluid) and proliferation was monitored. In addition, the establishment of new MPM cell cultures, derived from MPE specimens, was attempted by seeding the cells in 100% MPE fluid.

RESULTS

All established cancer cell cultures proliferated with similar growth rates in the different types of pleural fluid. Primary MPM cell culture success was similar with MPE fluid as with full culture medium.

CONCLUSIONS

Pleural fluid alone is adequate for cancer cell proliferation , regardless of the source of pleural fluid. These results support the hypothesis that pleural fluid has important pro-growth biological properties, but the mechanisms for this effect are unclear and likely not malignant effusion specific.

摘要

目的

恶性胸膜间皮瘤(MPM)或胸膜转移患者常伴有恶性胸腔积液(MPE)。本研究旨在分析胸腔积液对癌细胞的影响。

材料与方法

将源自MPE(MPM、乳腺癌、肺腺癌)的已建立的患者来源癌细胞培养物接种于100%胸腔积液(渗出性MPM MPE、漏出性MPE、非MPE漏出液)中,并监测其增殖情况。此外,尝试通过将细胞接种于100% MPE液中,从MPE标本中建立新的MPM细胞培养物。

结果

所有已建立好的癌细胞培养物在不同类型的胸腔积液中以相似的生长速率增殖。原发性MPM细胞培养成功率在MPE液中与在完全培养基中相似。

结论

无论胸腔积液来源如何,仅胸腔积液就足以支持癌细胞增殖。这些结果支持了胸腔积液具有重要的促生长生物学特性这一假说,但这种作用的机制尚不清楚,且可能并非恶性积液所特有。

相似文献

1
Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation.胸腔积液具有促进生长的生物学特性,可使癌细胞增殖。
Front Oncol. 2021 Apr 28;11:658395. doi: 10.3389/fonc.2021.658395. eCollection 2021.
2
Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid.恶性胸腔积液中效应记忆 CD8+T 细胞募集缺陷与正常胸腔积液比较。
BMC Cancer. 2013 Jul 2;13:324. doi: 10.1186/1471-2407-13-324.
3
Prediction modeling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients complicated with malignant pleural effusion.使用常规临床参数对合并恶性胸腔积液的恶性胸膜间皮瘤患者进行生存分层的预测模型。
Thorac Cancer. 2021 Dec;12(24):3304-3309. doi: 10.1111/1759-7714.14202. Epub 2021 Oct 26.
4
The Association Between Pleural Fluid Exposure and Survival in Pleural Mesothelioma.胸膜间皮瘤中胸腔液暴露与生存的关系。
Chest. 2021 Nov;160(5):1925-1933. doi: 10.1016/j.chest.2021.05.063. Epub 2021 Jun 11.
5
Malignant pleural fluid from mesothelioma has potent biological activities.来自间皮瘤的恶性胸腔积液具有强大的生物活性。
Respirology. 2017 Jan;22(1):192-199. doi: 10.1111/resp.12874. Epub 2016 Aug 25.
6
Clinical predictors and outcomes of non-expandable lung following percutaneous catheter drainage in lung cancer patients with malignant pleural effusion.肺癌合并恶性胸腔积液患者经皮穿刺置管引流后不扩张肺的临床预测因素及转归。
Medicine (Baltimore). 2023 Jun 30;102(26):e34134. doi: 10.1097/MD.0000000000034134.
7
Diagnostic Value of Computed Tomography Imaging Features in Malignant Pleural Mesothelioma.计算机断层扫描成像特征对恶性胸膜间皮瘤的诊断价值。
Respiration. 2020;99(1):28-34. doi: 10.1159/000503239. Epub 2019 Oct 25.
8
Pleural fluid microbiota as a biomarker for malignancy and prognosis.胸腔积液微生物组作为恶性肿瘤和预后的生物标志物。
Sci Rep. 2023 Feb 8;13(1):2229. doi: 10.1038/s41598-023-29001-4.
9
Clinical importance of serum and pleural fluid prominin-1 and hypoxia-inducible factor-1α concentration in the evaluation of lymph node involvement in patients with malignant pleural effusion.血清和胸腔液中 Prominin-1 和缺氧诱导因子-1α 浓度在评估恶性胸腔积液患者淋巴结受累中的临床意义。
Biochem Med (Zagreb). 2023 Oct 15;33(3):030701. doi: 10.11613/BM.2023.030701.
10
mRNA markers associated with malignant pleural effusion.与恶性胸腔积液相关的 mRNA 标志物。
Sci Rep. 2023 Apr 24;13(1):6677. doi: 10.1038/s41598-023-32872-2.

引用本文的文献

1
Malignant Pleural Effusion: A Multidisciplinary Approach.恶性胸腔积液:多学科治疗方法
Open Respir Arch. 2024 Jun 19;6(4):100349. doi: 10.1016/j.opresp.2024.100349. eCollection 2024 Oct-Dec.
2
Malignant pleural effusion: current understanding and therapeutic approach.恶性胸腔积液:当前的认识和治疗方法。
Respir Res. 2024 Jan 19;25(1):47. doi: 10.1186/s12931-024-02684-7.
3
MicroRNAs Present in Malignant Pleural Fluid Increase the Migration of Normal Mesothelial Cells In Vitro and May Help Discriminate between Benign and Malignant Effusions.

本文引用的文献

1
Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments.患者来源的恶性胸膜间皮瘤细胞培养物:推进生物标志物驱动治疗的工具。
Thorax. 2020 Nov;75(11):1004-1008. doi: 10.1136/thoraxjnl-2020-215027. Epub 2020 Sep 17.
2
Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline.恶性胸腔积液的处理。美国胸科学会/胸外科学会/胸外科医师学会临床实践指南官方版。
Am J Respir Crit Care Med. 2018 Oct 1;198(7):839-849. doi: 10.1164/rccm.201807-1415ST.
3
Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.
恶性胸腔积液中的 microRNAs 增加正常间皮细胞的体外迁移,可能有助于区分良性和恶性胸腔积液。
Int J Mol Sci. 2023 Sep 13;24(18):14022. doi: 10.3390/ijms241814022.
4
Malignant ascites supernatant enhances the proliferation of gastric cancer cells partially via the upregulation of asparagine synthetase.恶性腹水上清液部分通过上调天冬酰胺合成酶来增强胃癌细胞的增殖。
Oncol Lett. 2023 Aug 10;26(4):418. doi: 10.3892/ol.2023.14005. eCollection 2023 Oct.
5
Malignant pleural effusion diagnosis and therapy.恶性胸腔积液的诊断与治疗。
Open Life Sci. 2023 Feb 28;18(1):20220575. doi: 10.1515/biol-2022-0575. eCollection 2023.
6
Malignant pleural effusion: Updates in diagnosis, management and current challenges.恶性胸腔积液:诊断、管理及当前挑战的最新进展
Front Oncol. 2022 Nov 17;12:1053574. doi: 10.3389/fonc.2022.1053574. eCollection 2022.
7
Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?类器官作为恶性胸膜间皮瘤精准医学的模型:我们目前进展如何?
Cancers (Basel). 2022 Aug 2;14(15):3758. doi: 10.3390/cancers14153758.
8
Inflammation of the Pleural Cavity: A Review on Pathogenesis, Diagnosis and Implications in Tumor Pathophysiology.胸腔炎症:关于发病机制、诊断及在肿瘤病理生理学中的意义的综述
Cancers (Basel). 2022 Mar 10;14(6):1415. doi: 10.3390/cancers14061415.
患者来源肿瘤细胞的药物基因组学全景分析为精准肿瘤治疗提供信息。
Nat Genet. 2018 Oct;50(10):1399-1411. doi: 10.1038/s41588-018-0209-6. Epub 2018 Sep 27.
4
Cancer cell lines as patient avatars for drug response prediction.作为用于药物反应预测的患者替身的癌细胞系。
Nat Genet. 2018 Oct;50(10):1350-1351. doi: 10.1038/s41588-018-0245-2.
5
ERS/EACTS statement on the management of malignant pleural effusions.ERS/EACTS 声明:恶性胸腔积液的处理。
Eur J Cardiothorac Surg. 2019 Jan 1;55(1):116-132. doi: 10.1093/ejcts/ezy258.
6
ERS/EACTS statement on the management of malignant pleural effusions.ERS/EACTS 声明:恶性胸腔积液的管理
Eur Respir J. 2018 Jul 27;52(1). doi: 10.1183/13993003.00349-2018. Print 2018 Jul.
7
British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma.英国胸科学会恶性胸膜间皮瘤调查与管理指南。
Thorax. 2018 Mar;73(Suppl 1):i1-i30. doi: 10.1136/thoraxjnl-2017-211321.
8
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.恶性胸膜间皮瘤:调查、诊断与治疗的最新进展
Eur Respir Rev. 2016 Dec;25(142):472-486. doi: 10.1183/16000617.0063-2016.
9
Malignant pleural fluid from mesothelioma has potent biological activities.来自间皮瘤的恶性胸腔积液具有强大的生物活性。
Respirology. 2017 Jan;22(1):192-199. doi: 10.1111/resp.12874. Epub 2016 Aug 25.
10
Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics.肿瘤衍生细胞系作为癌症药物基因组学的分子模型
Mol Cancer Res. 2016 Jan;14(1):3-13. doi: 10.1158/1541-7786.MCR-15-0189. Epub 2015 Aug 6.